Registry for patients with extracranial carotid artery aneurysms
Extracranial Carotid Artery Aneurysm Registry
This study is collecting information from patients with carotid artery aneurysms to see how the condition progresses and how well different treatments work.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years to 120 Years |
| Sex | All |
| Sponsor | UMC Utrecht Academic / other |
| Locations | 1 site (Utrecht) |
| Trial ID | NCT02229370 on ClinicalTrials.gov |
What this trial studies
The Carotid Aneurysm Registry (CAR) is a prospective observational initiative designed to collect data on extracranial carotid artery aneurysms (ECAA) and their treatment. Conducted by the Department of Vascular Surgery at University Medical Centre Utrecht, the study aims to assess the natural history of ECAA and evaluate the success and safety of various treatment strategies. Patients diagnosed with ECAA will be enrolled regardless of their treatment choice, and follow-up will proceed as per standard clinical practice without interference from the study. The primary endpoint focuses on freedom from aneurysm-related symptoms at specified follow-up intervals.
Who should consider this trial
Good fit: Ideal candidates for this registry are individuals aged 18 and older diagnosed with an extracranial carotid artery aneurysm.
Not a fit: Patients without a diagnosis of extracranial carotid artery aneurysm will not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of ECAA and improve treatment strategies, ultimately benefiting patients with this condition.
How similar studies have performed: While this registry approach is common, the specific focus on ECAA may provide novel insights into this less-studied condition.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individual has one or more aneurysms of the extracranial carotid artery. Defined as 150% dilatation of the normal vessel diameter, or any saccular aneurysm. * Individual is ≥18 years of age. * Individual has signed informed consent Exclusion Criteria: * none
Where this trial is running
Utrecht
- University Medical Center Utrecht — Utrecht, Netherlands (Recruiting)
Study contacts
- Principal investigator: Gert Jan de Borst, MD, PhD — UMC Utrecht
- Study coordinator: Gert Jan de Borst, MD, PhD
- Email: g.j.deBorst-2@umcutrecht.nl
- Phone: +31-88-7556965
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.